Integrating serum pharmacology, network pharmacology, and molecular biology analysis to reveal the mechanisms of Baihe Dihuang decoction in treating Alzheimer's disease.

Overview

1. College of Laboratory Animal Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, China
2. Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, China
3. National and Local Joint Engineering Laboratory for Integrated Chinese and Western Medicine Prevention and Treatment Technology on Cardio-Brain Diseases, Liaoning University of Traditional Chinese Medicine, Shenyang, China

Abstract

Aim: This study aimed to evaluate the potential neuroprotecive effects of Baihe Dihuang Decoction (BDD) in APP/PS1 double-transgenic (TG) mice and to investigate the role of the gut-brain axis (GBA) using an integrated approach combining serum pharmacology, network pharmacology, and molecular biology.

Materials and methods: The blood-borne bioactive components of BDD were initially identified using UPLC-Q-Orbitrap HRMS. Subsequently, network pharmacology was employed to prioritize key therapeutic targets and elucidate the primary pathways underlying the anti-Alzheimer’s disease (AD) effects of BDD. The neuroprotective efficacy of BDD in TG mice was systematically evaluated using the morris water maze (MWM) test, histopathological observation (HE staining), transmission electron microscope (TEM) test, and ELISA-based inflammatory cytokine assays. The potential mechanisms were further elucidated by integrating network pharmacology with 16S ribosomal RNA (16S rRNA) sequencing. Finally, molecular docking and Western blotting (WB) were performed to validate the interactions within the identified pathways.

Results: A total of 49 BDD-derived compounds were identified in serum samples. Network pharmacology revealed 116 common targets of BDD against AD. Remarkably, KEGG analysis highlighted 57 signaling pathways potentially involved in the anti-AD effects of BDD. Pharmacodynamic analysis showed that BDD ameliorated cognitive impairment in TG mice, mitigated pathological damage, and suppressed the release of IL-6, IL-1β, and TNF-α in the colon, brain, and serum. Moreover, 16S rRNA sequencing indicated that BDD modulated gut microbiota (GM) structure and restored intestinal flora imbalance in TG mice. Integrative analysis of network pharmacology and GM analysis identified several Key pathways (FoxO, MAPK, PI3K-Akt, HIF-1, Th17, IL-17, and Toll/Imd) and core anti-AD targets (TLR4, PTGS2, SIRT1, BDNF, NF-κB, STAT3, JAK2, EGFR, GSK3β, and CD86). Molecular docking results showed that the five complexes with the lowest docking scores (TLR4-salidroside, NF-κB-glabranin, TRKB-alantolactone, PTGS2-3′_4′_dihydroxyflavone, and SIRTI-abietic acid) exhibited strong binding affinity. QSAR and WB analyses further demonstrated the modulatory effects of BDD on these five core targets.

Conclusion: This study demonstrated that BDD effectively restored GM structure and ameliorated cognitive impairment in TG mice, thereby exerting therapeutic effects against AD. These findings support BDD as a potential traditional Chinese medicine (TCM) strategy for AD treatment.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• figshare:32725812, at figshare; found in “Data availability statement”

Data availability statement

The data presented in the study are deposited in the NCBI Sequence Read Archive (SRA) repository, accession number: PRJNA1480963. Additional data can be found in the Figshare data repository, doi: 10.6084/m9.figshare.32725812 (https://doi.org/10.6084/m9.figshare.32725812). Further inquiries can be directed to the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 4 authors, 5 keywords, 40 references.

Cite

This paper

Liang, X., Ning, T., Wang, Y., & Zhan, L. (2026). Integrating serum pharmacology, network pharmacology, and molecular biology analysis to reveal the mechanisms of Baihe Dihuang decoction in treating Alzheimer's disease. Frontiers in microbiology, 17, 1765044. https://doi.org/10.3389/fmicb.2026.1765044

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fnins.2026.1849896

Dynamic changes of gut microbiota during progression of three Alzheimer's disease mice models.

Journal: Frontiers in neuroscience

In common: Alzheimer's / dementia, mouse, 2 references

[2] doi:10.3389/fphar.2026.1830927

<i>Astragalus polysaccharide</i> alleviates neuropathology and cognitive deficits by modulating gut microbiota and neuroinflammation in an Alzheimer's disease model.

Journal: Frontiers in pharmacology

In common: histology / microscopy, Alzheimer's / dementia, genetics / omics, 2 other categories, 1 reference

[3] doi:10.1186/s12974-026-03761-y

Clostridium butyricum ameliorates Toxoplasma gondii-induced neuropsychiatric disorders by attenuating glial-mediated synaptic pruning via the gut-brain axis.

Journal: Journal of neuroinflammation

In common: mouse, cellular / molecular, 2 references

[4] doi:

Gut microbiota dysbiosis is associated with hippocampal neuronal damage and behavioral alterations in APP/PS1 mice with high-salt diet

Journal: Frontiers in microbiology

In common: histology / microscopy, Alzheimer's / dementia, genetics / omics, 1 other category, 1 reference

[5] doi:10.1016/j.xcrm.2026.102655 [code]

An integrative multi-omics approach identifies microbiome alterations linked to pathological and behavioral features in autism spectrum disorder.

Journal: Cell reports. Medicine

In common: genetics / omics, 2 references

[6] doi:10.3390/ijms27125533 [code]

Discovery-Driven Plasma Proteomics Identifies a Multi-Protein Signature for Amyloid PET Positivity: A Machine Learning Analysis of the Bio-Hermes Cohort.

Journal: International journal of molecular sciences

In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 1 reference

[7] doi:10.1016/j.tjpad.2026.100601

Identification of a CD44-dependent control of astrocytic autophagic activity in Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

In common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 1 reference

[8] doi:10.1038/s41467-026-74775-6

Select microbial metabolites promote tau aggregation in a murine tauopathy model.

Journal: Nature communications

In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference

[9] doi:10.1186/s13024-026-00956-y [code]

In vivo profiling of astrocyte secretome reveals brain-region specific regulatory networks in a mouse model of amyloid pathology.

Journal: Molecular neurodegeneration

In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference

[10] doi:10.1038/s43587-026-01149-4 [code]

The blood metabolome of brain health in midlife and influences of genes, microbiome and exposome.

Journal: Nature aging

In common: Alzheimer's / dementia, genetics / omics, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.